| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Larry A. Donoso Laboratory for Eye Research, Academic Department of Ophthalmology, Queen’s Medical Centre, University Hospital Nottingham, United Kingdom; and the 2 Department of Ophthalmology, University of Aberdeen, Medical School, Foresterhill, Aberdeen, Scotland, United Kingdom.
PURPOSE. Defensins are naturally occurring antimicrobial peptides. Recently the authors published evidence of defensin production by the human ocular surface. A study was undertaken to look for intraocular defensins that may account for unexplained antimicrobial activity of intraocular fluids.
METHODS. Reverse transcription–polymerase chain reaction (RT–PCR) was performed on human postmortem ciliary body samples for beta defensins-1 (HBD-1) and beta defensin-2 (HBD-2), and alpha defensins 5 and 6. Induction of defensins by cytokines was analyzed in cultured human ciliary body epithelial (CBE) and retinal pigment epithelial (RPE) cells. Polyclonal antibodies were used to immunoblot aqueous and vitreous to detect HBD-1 and HBD-2 and to estimate their concentration.
RESULTS. RT–PCR revealed constitutive HBD-1 message in ciliary body. HBD-2 and alpha defensin 5 and 6 messages were absent. HBD-2 message was induced by cytokine stimulation of both CBE and RPE cells. Immunoblots of vitreous and aqueous stained positively for HBD-1 but not HBD-2. The estimated aqueous concentration of HBD-1 was less than 16 ng/ml.
CONCLUSIONS. This study demonstrates that HBD-1 is constitutively present in the aqueous and vitreous, probably at sub-bacteriocidal concentrations. HBD-2 was absent from aqueous, but cytokine stimulation studies suggest that it may be generated in response to inflammatory cytokines during infections. HBD-2 has a wider antibacterial spectrum, is 10-fold more potent, and may play a more significant role in antimicrobial defense than HBD-1. The use of defensins therapeutically may be indicated; however, caution is required because defensins also promote cell proliferation and fibrin formation, which are 2 key elements in ocular scarring processes such as proliferative vitreoretinopathy.
This article has been cited by other articles:
|
|
 |
|
  A. Abedin, I. Mohammed, A. Hopkinson, and H. S. Dua A Novel Antimicrobial Peptide on the Ocular Surface Shows Decreased Expression in Inflammation and Infection Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Huang, R. L. Redfern, S. Narayanan, R. Y. Reins, and A. M. McDermott In Vitro Activity of Human {beta}-Defensin 2 against Pseudomonas aeruginosa in the Presence of Tear Fluid Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3853 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Carter, A. J Churchill, C. Gorman, and R. Haynes A case of bilateral endophthalmitis and carriage of {beta}-defensin 1 44CC genotype Br J Ophthalmol, September 1, 2007; 91(9): 1249 - 1250. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Weinberg, M.E. Quinones-Mateu, and M.M. Lederman Role of Human {beta}-defensins in HIV Infection Advances in Dental Research, April 1, 2006; 19(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Rodriguez-Martinez, M E Cancino-Diaz, and J C Cancino-Diaz Expression of CRAMP via PGN-TLR-2 and of {alpha}-defensin-3 via CpG-ODN-TLR-9 in corneal fibroblasts. Br J Ophthalmol, March 1, 2006; 90(3): 378 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. K. Harvey, E. G. Romanowski, K. A. Yates, and Y. J. Gordon Adenovirus-Directed Ocular Innate Immunity: The Role of Conjunctival Defensin-like Chemokines (IP-10, I-TAC) and Phagocytic Human Defensin-{alpha} Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3657 - 3665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Rodriguez-Martinez, M E Cancino-Diaz, L Jimenez-Zamudio, E Garcia-Latorre, and J C Cancino-Diaz TLRs and NODs mRNA expression pattern in healthy mouse eye Br J Ophthalmol, July 1, 2005; 89(7): 904 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. McIntosh, J. E. Cade, M. Al-Abed, V. Shanmuganathan, R. Gupta, A. Bhan, P. J. Tighe, and H. S. Dua The Spectrum of Antimicrobial Peptide Expression at the Ocular Surface Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1379 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Narayanan, W. L. Miller, and A. M. McDermott Expression of Human {beta}-Defensins in Conjunctival Epithelium: Relevance to Dry Eye Disease Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3795 - 3801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. McDermott, R. L. Redfern, B. Zhang, Y. Pei, L. Huang, and R. J. Proske Defensin Expression by the Cornea: Multiple Signalling Pathways Mediate IL-1{beta} Stimulation of hBD-2 Expression by Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1859 - 1865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Paulsen, T. Pufe, U. Schaudig, J. Held-Feindt, J. Lehmann, J.-M. Schroder, and B. N. Tillmann Detection of Natural Peptide Antibiotics in Human Nasolacrimal Ducts Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2157 - 2163. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
